Anúncio
Anúncio

ULBI

ULBI logo

Ultralife Corporation

5.96
USD
Patrocinado
+0.17
+3.03%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

5.96

0.00
0.00%

Relatórios de Lucros ULBI

Rácio de surpresa positiva

ULBI separação 7 de 19 últimas estimativas.

37%

Próximo Relatório

Data do Próximo Relatório
29 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$58.14M
/
$0.27
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+34.06%
/
-485.71%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+32.58%
/
+2600.00%

Ultralife Corporation earnings per share and revenue

On 18 de nov. de 2025, ULBI reported earnings of -0.07 USD per share (EPS) for Q3 25, missing the estimate of 0.22 USD, resulting in a -131.19% surprise. Revenue reached 43.37 milhão, compared to an expected 54.06 milhão, with a -19.77% difference. The market reacted with a -8.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of 0.27 USD, with revenue projected to reach 58.14 milhão USD, implying an diminuir of -485.71% EPS, and aumentar of 34.06% in Revenue from the last quarter.
FAQ
For Q3 2025, Ultralife Corporation reported EPS of -$0.07, missing estimates by -131.19%, and revenue of $43.37M, -19.77% below expectations.
The stock price moved down -8.84%, changed from $5.54 before the earnings release to $5.05 the day after.
The next earning report is scheduled for 29 de jan. de 2026.
Based on 3 analistas, Ultralife Corporation is expected to report EPS of $0.27 and revenue of $58.14M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio